J\u0101\u0146a Buksa Aizie\u0161ana no AS “Olpha” Padomes Priek\u0161s\u0113d\u0113t\u0101ja Amata<\/p>\n
J\u0101nis Buks, ilggad\u0113js AS “Olpha” padomes priek\u0161s\u0113d\u0113t\u0101js, pl\u0101no atst\u0101t savu amatu no 2026. gada 1. janv\u0101ra. \u0160is l\u0113mums, kas tika izzi\u0146ots \u0161odien, 11. decembr\u012b, 2025. gad\u0101, iez\u012bm\u0113 noz\u012bm\u012bgu pav\u0113rsienu uz\u0146\u0113muma vad\u012bbas strukt\u016br\u0101. Buks ir pie\u0146\u0113mis strat\u0113\u0123isku l\u0113mumu piln\u012bb\u0101 piev\u0113rsties sava person\u012bg\u0101 biznesa konsult\u0101ciju uz\u0146\u0113muma att\u012bst\u012bbai, kas liecina par jauniem karjeras izaicin\u0101jumiem un amb\u012bcij\u0101m.<\/p>\n
P\u0113c Buka aizie\u0161anas AS “Olpha” padome turpin\u0101s savu darb\u012bbu piecu cilv\u0113ku sast\u0101v\u0101, nodro\u0161inot nep\u0101rtraukt\u012bbu un stabilit\u0101ti uz\u0146\u0113muma korporat\u012bvaj\u0101 p\u0101rvald\u012bb\u0101. Lai gan prec\u012bzi iemesli un jaun\u0101 virziena deta\u013cas netiek pla\u0161i atkl\u0101tas, \u0161\u0101ds solis liecina par r\u016bp\u012bgi p\u0101rdom\u0101tu pl\u0101nu n\u0101kotnei.<\/p>\n
J\u0101\u0146a Buksa Profesion\u0101l\u0101 Ce\u013cve\u017ea Atspulgs<\/p>\n
J\u0101\u0146a Buksa karjera ir bag\u0101ta un daudzpus\u012bga, sniedzoties p\u0101ri farm\u0101cijas nozarei. Vi\u0146a pieredze jurista, finansista un sporta funkcion\u0101ra lom\u0101s ir veidojusi vi\u0146u par zino\u0161u un kompetentu vad\u012bt\u0101ju. Pirms pievieno\u0161an\u0101s AS “Olpha” vad\u012bbai 2019. gad\u0101, Buks ie\u0146\u0113ma noz\u012bm\u012bgus amatus finan\u0161u sektor\u0101, tostarp bija Nordea Bankas Latvijas fili\u0101les vad\u012bt\u0101js un Luminor Bankas valdes loceklis. \u0160\u012b pieredze finan\u0161u tirg\u016b noteikti ir devusi vi\u0146am dzi\u013cu izpratni par uz\u0146\u0113mumu vad\u012bbu un strat\u0113\u0123isko att\u012bst\u012bbu. Vi\u0146a CV v\u0113st\u012b ar\u012b par akt\u012bvu darb\u012bbu sporta pasaul\u0113, ie\u0146emot Latvijas Olimpisk\u0101s komitejas prezidenta amatu, kas apliecina vi\u0146a sp\u0113ju vad\u012bt un motiv\u0113t da\u017e\u0101d\u0101s jom\u0101s. Buks ir ar\u012b bijis AS “Olainfarm” (tagad AS “Olpha”) padomes priek\u0161s\u0113d\u0113t\u0101ja vietnieks pirms k\u013c\u016b\u0161anas par padomes priek\u0161s\u0113d\u0113t\u0101ju. \u0160is pla\u0161ais profesion\u0101lais redzesloks var\u0113tu b\u016bt bijis noz\u012bm\u012bgs faktors vi\u0146a l\u0113mum\u0101 mekl\u0113t jaunus izaicin\u0101jumus sav\u0101 priv\u0101taj\u0101 biznes\u0101.<\/p>\n
Aizie\u0161ana no AS “Olpha” noz\u012bm\u0113, ka Buks p\u0101rtrauks savu gandr\u012bz desmit gadu ilgo darb\u012bbu uz\u0146\u0113muma vad\u012bb\u0101, kuras laik\u0101 vi\u0146\u0161 ir piedz\u012bvojis un vad\u012bjis b\u016btiskas p\u0101rmai\u0146as un att\u012bst\u012bbas ciklus. Vi\u0146\u0161 ir atzinis, ka pievienojoties uz\u0146\u0113muma vad\u012bbas komandai, ir redz\u0113jis gandr\u012bz visu biznesa att\u012bst\u012bbas ciklu, tostarp sare\u017e\u0123\u012btus p\u0101rmai\u0146u periodus. Tas liecina par dzi\u013cu ieguld\u012bjumu un izpratni par uz\u0146\u0113muma dinamiku.<\/p>\n
AS “Olpha” un T\u0101s N\u0101kotnes Virzieni<\/p>\n
AS “Olpha”, kas agr\u0101k bija paz\u012bstama k\u0101 “Olainfarm”, ir stabils un ilggad\u0113js farm\u0101cijas nozares sp\u0113l\u0113t\u0101js Latvij\u0101 ar bag\u0101tu v\u0113sturi, kas aizs\u0101k\u0101s jau 1972. gad\u0101. Uz\u0146\u0113mums specializ\u0113jas medikamentu un \u0137\u012bmiski farmaceitisko produktu izstr\u0101d\u0113, ra\u017eo\u0161an\u0101 un tirdzniec\u012bb\u0101, ar \u012bpa\u0161u fokusu uz nervu sist\u0113mas, sirds un asinsvadu vesel\u012bbas l\u012bdzek\u013ciem, k\u0101 ar\u012b antibakteri\u0101lajiem, pretv\u012brusu un pretaler\u0123ijas prepar\u0101tiem. Tiek prognoz\u0113ts, ka p\u0113c J\u0101\u0146a Buksa aizie\u0161anas, uz\u0146\u0113muma padome turpin\u0101s darbu piecu cilv\u0113ku sast\u0101v\u0101, nodro\u0161inot nep\u0101rtraukt\u012bbu un strat\u0113\u0123isko virz\u012bbu. Neskatoties uz izmai\u0146\u0101m augst\u0101kaj\u0101 vad\u012bb\u0101, uz\u0146\u0113mums turpina att\u012bst\u012bties, nesen invest\u0113jot 4,4 miljonus eiro jaun\u0101s medikamentu ra\u017eo\u0161anas iek\u0101rt\u0101s. \u0160\u012b invest\u012bcija apliecina uz\u0146\u0113muma ap\u0146em\u0161anos uzlabot ra\u017eo\u0161anas procesus un papla\u0161in\u0101t savu produktu kl\u0101stu. Turkl\u0101t nesen\u0101s vad\u012bbas komandas sast\u0101va izmai\u0146as un sasniegumi, piem\u0113ram, Vesel\u012bbas ministrijas pateic\u012bbas raksta sa\u0146em\u0161ana no AS “Olpha” valdes priek\u0161s\u0113d\u0113t\u0101ja Jura Bundu\u013ca, liecina par pozit\u012bvu att\u012bst\u012bbas dinamiku. Tas nor\u0101da, ka, lai gan J\u0101nis Buks atst\u0101s savu amatu, uz\u0146\u0113mums ir gatavs n\u0101kotnei un turpin\u0101s savu att\u012bst\u012bbu.<\/p>\n
Interesanti ir v\u0113rot, k\u0101 uz\u0146\u0113mumi Latvij\u0101 un pasaul\u0113 veic vad\u012bbas mai\u0146as. K\u0101 nor\u0101d\u012bts k\u0101d\u0101 anal\u012bz\u0113, viena no bie\u017e\u0101kaj\u0101m p\u0101rmai\u0146\u0101m Latvijas uz\u0146\u0113mumos ir vad\u012bbas komandas mai\u0146a. Tas var b\u016bt saist\u012bts ar da\u017e\u0101diem faktoriem, s\u0101kot no strategisk\u0101m izmai\u0146\u0101m l\u012bdz pat neparedz\u0113t\u0101m situ\u0101cij\u0101m. Tom\u0113r, k\u0101 uzsver eksperti, veiksm\u012bga p\u0101rmai\u0146u vad\u012b\u0161ana prasa r\u016bp\u012bgu pl\u0101no\u0161anu, skaidru komunik\u0101ciju un darbinieku iesaist\u012b\u0161anu. “Olpha” gad\u012bjum\u0101, kad padomes priek\u0161s\u0113d\u0113t\u0101js dodas prom, uz\u0146\u0113muma strat\u0113\u0123ija un m\u0113r\u0137i, visticam\u0101k, tiks saglab\u0101ti, nodro\u0161inot stabilit\u0101ti un turpinot iepriek\u0161 ies\u0101kto darbu.<\/p>\n","protected":false},"excerpt":{"rendered":"J\u0101\u0146a Buksa Aizie\u0161ana no AS “Olpha” Padomes Priek\u0161s\u0113d\u0113t\u0101ja Amata J\u0101nis Buks, ilggad\u0113js AS “Olpha” padomes priek\u0161s\u0113d\u0113t\u0101js, pl\u0101no atst\u0101t…\n","protected":false},"author":2,"featured_media":72630,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[18476,77,76,16540,18331,35,39,38,36,37,34,40,18477,5233],"class_list":{"0":"post-72629","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-bizness","8":"tag-as-olpha","9":"tag-bizness","10":"tag-business","11":"tag-farmacijas-nozare","12":"tag-janis-buks","13":"tag-latvia","14":"tag-latvian","15":"tag-latviesu","16":"tag-latviesu-valoda","17":"tag-latviesuvaloda","18":"tag-latvija","19":"tag-lv","20":"tag-padomes-priekssedetajs","21":"tag-vadibas-maina"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115707744296327195","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/72629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=72629"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/72629\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/72630"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=72629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=72629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=72629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}